Voluntary Plan Gives Animal Industry 3 Years to Stop Antibiotic Overuse in Food Animals
April 11, 2012 -- The FDA today said it's giving the food industry three years to voluntarily stop using antibiotics to make food animals grow faster.
But the practice is fast creating new strains of drug-resistant superbugs that threaten human health, according to the FDA, the World Health Organization, the American Medical Association, and other public health groups.
Thirty-five years ago, the FDA issued a formal finding that use of antibiotics should be banned. Consumer groups sued and petitioned the FDA to act on this finding. In December 2011 the FDA withdrew the finding.
Now the FDA has taken action. Today the agency made final its June 2011 "guidance" asking the food industry to voluntarily stop feeding antibiotics to animals in order to make them grow faster.
Why no ban? The FDA says it would take too long and cost too much. And the food industry is ready to make the change, Michael Taylor, the FDA deputy commissioner for foods, said today at a news teleconference.
"There has been a sea change in the willingness of government, drug companies, and the animal industry to solve the problem of antimicrobial drug resistance," Taylor said. "We have been pleased with the response we have received since 2010."
Cuting Antibiotic Use in Food Animals
Under the FDA's voluntary plan:
- The food industry would give antibiotics to animals only under the supervision of a veterinarian.
- Veterinarians would prescribe antibiotics for food animals only to prevent, control, or treat specific diseases.
- Drugmakers would voluntarily change antibiotic drug labels to indicate use of the drugs only when the animals' health is threatened, and only with veterinarian oversight or consultation. A draft of this proposal was issued today and is open for public comment for 90 days.
- New rules will govern the use of antimicrobial drugs in animal feed. A draft of the new rules was issued today and is open for public comment for 90 days.
- The FDA will phase in the plan over the next three years. After that time, the FDA promises to check on how the plan is working and to take stronger action if it isn't.